Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-28

FDA Approved: FEBUXOSTAT — Original Application (Solco Healthcare US LLC)

View source ↗

Summary

FDA approved an original abbreviated new drug application for febuxostat submitted by Solco Healthcare US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)